利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

14 条记录 (耗时 0.026 秒)

    DEVICES, SYSTEMS, AND METHODS FOR AIDING IN THE DETECTION OF A PHYSIOLOGICAL ABNORMALITY
    8.
    发明申请
    DEVICES, SYSTEMS, AND METHODS FOR AIDING IN THE DETECTION OF A PHYSIOLOGICAL ABNORMALITY 审中-公开
    用于检测生理异常的装置，系统和方法

    公开(公告)号：US20110009764A1

    公开(公告)日：2011-01-13

    申请号：US12835548

    申请日：2010-07-13

    申请人： Gregory R. Lanier ,  Derek Kane

    发明人： Gregory R. Lanier ,  Derek Kane

    IPC分类号： A61B5/08

    CPC分类号： A61B5/0836 ,  A61B5/0833 ,  A61B5/087 ,  A61B5/097 ,  A61B5/411 ,  A61B5/417 ,  A61B5/743 ,  A61B5/7435 ,  A61B2560/0252 ,  A61B2560/0431 ,  A61B2560/0462

    摘要： The present invention comprises a method for excluding the presence of a pulmonary embolism using a combination of a blood test for D-dimer and a carboximetry test measuring the ratio of exhaled CO2 to O2. If the measured D-Dimer value is at or above a threshold indicative of concern and the carboximetry value is equal to or greater than a pre-determined carboximetry ratio threshold, a clinically significant pulmonary embolism, or a pulmonary thrombus above a certain effective size, is unlikely to be present. If the measured D-Dimer value is at or above a threshold indicative of concern and the respiratory analysis yields a carboximetry ratio less than the carboximetry ratio threshold, test results are inconclusive and additional testing may be required to determine whether a clinically significant pulmonary embolism, or a pulmonary thrombus above a specified size is present. The present invention also comprises a method for diagnosing or excluding the presence of respiratory dysfunction in an individual by using carboximetry values corresponding to an end-tidal volume of an exhaled breath that is a pre-determined multiple of the individual's estimated pulmonary dead space. In one aspect, a linear regression function is used to represent the CO2/O2 ratio derived from the measured CO2 and O2 values in an exhaled breath, and the function is used to determine the CO2/O2 ratio corresponding to the pre-determined end-tidal volume.

    摘要翻译： 本发明包括使用D-二聚体的血液检验和测量呼出的二氧化碳与O 2的比例的氧化测定法的组合来排除肺栓塞的存在的方法。 如果所测量的D-二聚体值等于或高于指示关注的阈值，并且所述碳氧比值等于或大于预定的氧化比例阈值，临床显着的肺栓塞或高于某一有效大小的肺血栓， 不太可能存在。 如果测量的D-二聚体值等于或高于表示关注的阈值，并且呼吸分析产生小于碳氧比例阈值的碳水化合物比例，则测试结果是不确定的，并且可能需要额外的测试来确定是否临床上显着的肺栓塞， 或者存在高于规定尺寸的肺血栓。 本发明还包括通过使用对应于作为个体估计的肺静脉空间的预定倍数的呼气呼吸的终止潮气量的氧化值来诊断或排除个体中呼吸功能障碍的存在的方法。 在一个方面，使用线性回归函数来表示从呼出气体中测量的CO 2和O 2值得到的CO 2 / O 2比例，并且该功能用于确定对应于预定终端的CO 2 / 潮量。

    Method and system for determining total cost of ownership
    9.
    发明授权
    Method and system for determining total cost of ownership 有权
    确定总拥有成本的方法和系统

    公开(公告)号：US08538792B1

    公开(公告)日：2013-09-17

    申请号：US13456907

    申请日：2012-04-26

    申请人： Derek Kane

    发明人： Derek Kane

    IPC分类号： G06Q40/00

    CPC分类号： G06Q10/063 ,  G06Q10/06 ,  G06Q40/06

    摘要： Embodiments of the present invention are directed to a total cost of ownership method and system for technology components, applications or business units. The system provides financial reporting costs in information technology terms in order to build a bridge between technology and finance organizations. The method and system utilize data from systems of record for assets and charges, extract this data and deliver output reports and visualizations on the data processing and analysis in order to drive a Total Cost of Ownership for technology components, applications or business units. The method includes bringing data from disparate sources into the computer processor accessing at least one storage medium, validating the data by a Data Quality Engine, processing the data by matching the at least one charge to the at least one asset and performing data analytics and reporting on the Total Cost of Ownership.

    摘要翻译： 本发明的实施例涉及技术组件，应用或业务单元的总体拥有成本方法和系统。 该系统以信息技术术语提供财务报告成本，以便在技术和金融机构之间建立桥梁。 该方法和系统利用来自资产和收费记录系统的数据，提取数据并提供数据处理和分析的输出报告和可视化，以便为技术组件，应用程序或业务单位带来总体拥有成本。 该方法包括将来自不同来源的数据引入计算机处理器访问至少一个存储介质，由数据质量引擎验证数据，通过将至少一个费用与至少一个资产进行匹配来处理数据，以及执行数据分析和报告 关于总体拥有成本。

    DEVICES, SYSTEMS, AND METHODS FOR AIDING IN THE DETECTION OF A PHYSIOLOGICAL ABNORMALITY
    10.
    发明申请
    DEVICES, SYSTEMS, AND METHODS FOR AIDING IN THE DETECTION OF A PHYSIOLOGICAL ABNORMALITY 有权
    用于检测生理异常的装置，系统和方法

    公开(公告)号：US20100041062A1

    公开(公告)日：2010-02-18

    申请号：US12423352

    申请日：2009-04-14

    申请人： Gregory R. Lanier, JR. ,  Derek Kane

    发明人： Gregory R. Lanier, JR. ,  Derek Kane

    IPC分类号： G01N33/53

    CPC分类号： G01N33/68 ,  A61B5/0833 ,  A61B5/0836 ,  A61B5/087 ,  A61B5/097 ,  A61B5/417 ,  A61B5/743 ,  A61B5/7435 ,  A61B2560/0252 ,  A61B2560/0431 ,  A61B2560/0462 ,  Y10T436/20

    摘要： The present invention comprises a method for identifying the presence or absence of a pulmonary embolism using a combination of tests and brightline thresholds. The first test is a blood based test measuring D-Dimer concentration and the second test is a respiratory analysis that determines a carboximetry ratio. If the measured D-Dimer value is at or above a threshold indicative of concern and the carboximetry value is equal to or less than a carboximetry ratio threshold, pulmonary embolism is present. If the measured D-Dimer value is at or above a threshold indicative of concern and the respiratory analysis yields a carboximetry ratio greater than the carboximetry ratio threshold, test results are inconclusive and additional testing is required to determine whether a pulmonary embolism is present.

    摘要翻译： 本发明包括使用测试和亮点阈值的组合来识别肺栓塞的存在或不存在的方法。 第一个测试是测量D-二聚体浓度的基于血液的测试，第二个测试是确定碳摩尔比值的呼吸分析。 如果所测量的D二聚体值等于或高于表示关注的阈值，并且碳氧比值等于或小于碳氧比例阈值，则存在肺栓塞。 如果测量的D-二聚体值等于或高于表示关注的阈值，并且呼吸分析产生大于碳氧比例阈值的碳水化合物比例，则测试结果是不确定的，并且需要额外的测试来确定是否存在肺栓塞。